SGLT2 inhibitors (class)
Drug timelines are a Plus or Pro feature.
13 regulatory and trial events tracked for SGLT2 inhibitors (class), covering 2018-05-04 to 2026-03-25. Get the full timeline:
Most recent: Clinical Trial Update: Sodium-Glucose Cotransporter 2 Inhibitor Use in a National Heart Failure Telemonitoring Program